Deletion of hypoxia-inducible factor-1a in myeloid lineage exaggerates angiotensin II-induced formation of abdominal aortic aneurysm

Clinical Science

Volumn 131, Issue 7, 2017, Pages 609-620

  Takahara, Yusuke ^a   Tokunou, Tomotake ^a,b   Kojima, Hiroshi ^a   Hirooka, Yoshitaka ^a,b   Ichiki, Toshihiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; ANGIOTENSIN II; HISTONE H3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; BONE MARROW CELL; CELL INFILTRATION; CELL LINEAGE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ELASTICA VAN GIESON STAINING; HEMODYNAMIC PARAMETERS; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; SURVIVAL RATE; VASCULAR REMODELING; ABDOMINAL AORTA; ABDOMINAL AORTIC ANEURYSM; ANIMAL; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HEMODYNAMICS; KNOCKOUT MOUSE; LIPID DIET; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL ANALYSIS; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEMODYNAMICS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACROPHAGES, PERITONEAL; MALE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; RNA, MESSENGER; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 85016401499     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160865     Document Type: Article

References (47)

1. Cosford, P. A. and Leng, G. C. (2007) Screening for abdominal aortic aneurysm. Cochrane Database Syst. Rev. 2, CD002945.
2. Aboyans, V., Bataille, V., Bliscaux, P., Ederhy, S., Filliol, D., Honton, B. et al. (2014) Effectiveness of screening for abdominal aortic aneurysm during echocardiography. Am. J. Cardiol. 114, 1100-1104.
3. Kristensen, K. E., Torp-Pedersen, C., Gislason, G. H., Egfjord, M., Rasmussen, H. B. and Hansen, P. R. (2015) Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study. Arterioscler. Thromb. Vasc. Biol. 35, 733-740.
4. Diehm, N. and Baumgartner, I. (2006) ACE inhibitors and abdominal aortic aneurysm. Lancet 368, 622-623.
5. Limet, R., Sakalihassan, N. and Albert, A. (1991) Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J. Vasc. Surg. 14, 540-548.
6. Rughani, G., Robertson, L. and Clarke, M. (2012) Medical treatment for small abdominal aortic aneurysms. Cochrane Database Syst. Rev. 9, CD009536
7. Semenza, G. L. (2001) HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107, 1-3.
8. Jiang, B. H., Rue, E., Wang, G. L., Roe, R. and Semenza, G. L. (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271, 17771-17778.
9. Huang, L. E., Gu, J., Schau, M. and Bunn, H. F. (1998) Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U. S. A. 95, 7987-7992.
10. Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D. et al. (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1, 401-408.
11. Daugherty, A. and Cassis, L. A. (2004) Mouse models of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 24, 429-434.
12. Dale, M. A., Ruhlman, M. K. and Baxter, B. T. (2015) Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy. Arterioscler. Thromb. Vasc. Biol. 35, 1746-1755.
13. Cramer, T., Yamanishi, Y., Clausen, B. E., Forster, I., Pawlinski, R., Mackman, N. et al. (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112, 645-657.
14. Ikeda, J., Ichiki, T., Matsuura, H., Inoue, E., Kishimoto, J., Watanabe, A. et al. (2013) Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling. J. Am. Heart Assoc. 2, e000178.
15. Watanabe, A., Ichiki, T., Sankoda, C., Takahara, Y., Ikeda, J., Inoue, E. et al. (2014) Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption. Clin. Sci. 126, 671-678.
16. Peshkova, I. O., Schaefer, G. and Koltsova, E. K. (2016) Atherosclerosis and aortic aneurysm - is inflammation a common denominator? FEBS J. 283, 1636-1652.
17. Sano, M., Sasaki, T., Hirakawa, S., Sakabe, J., Ogawa, M., Baba, S. et al. (2014) Lymphangiogenesis and angiogenesis in abdominal aortic aneurysm. PLoS One 9, e89830.
18. Daugherty, A., Manning, M. W. and Cassis, L. A. (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105, 1605-1612.
19. Kohashi, K., Hiromura, M., Mori, Y., Terasaki, M., Watanabe, T., Kushima, H. et al. (2016) A dipeptidyl peptidase-4 inhibitor but not incretins suppresses abdominal aortic aneurysms in angiotensin II-infused apolipoprotein E-null mice. J. Atheroscler. Thromb. 23, 441-454.
20. Daugherty, A., Manning, M. W. and Cassis, L. A. (2001) Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br. J. Pharmacol. 134, 865-870.
21. Watanabe, K., Fujioka, D., Saito, Y., Nakamura, T., Obata, J. E., Kawabata, K. et al. (2012) Group X secretory PLA2 in neutrophils plays a pathogenic role in abdominal aortic aneurysms in mice. Am. J. Physiol. Heart Circ. Physiol. 302, H95-H104.
22. Fong, G. H. and Takeda, K. (2008) Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 15, 635-641.
23. Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R. et al. (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732-744.
24. Church, D. M., Goodstadt, L., Hillier, L. W., Zody, M. C., Goldstein, S., She, X. et al. (2009) Lineage-specific biology revealed by a finished genome assembly of the mouse. PLoS Biol. 7, e1000112.
25. Golledge, J., Muller, J., Daugherty, A. and Norman, P. (2006) Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler. Thromb. Vasc. Biol. 26, 2605-2613.
26. Patel, M. I., Melrose, J., Ghosh, P. and Appleberg, M. (1996) Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J. Vasc. Surg. 24, 82-92.
27. Tamarina, N. A., McMillan, W. D., Shively, V. P. and Pearce, W. H. (1997) Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 122, 264-271, discussion 271-2.
28. Reeps, C., Kehl, S., Tanios, F., Biehler, J., Pelisek, J., Wall, W. A. et al. (2014) Biomechanics and gene expression in abdominal aortic aneurysm. J. Vasc. Surg. 60, 1640-1647 e1-2.
29. Cawston, T. E., Curry, V. A., Clark, I. M. and Hazleman, B. L. (1990) Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase. Biochem. J. 269, 183-187.
30. Murphy, G., Houbrechts, A., Cockett, M. I., Williamson, R. A., O'Shea, M. and Docherty, A. J. (1991) The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30, 8097-8102.
31. Chen, J. M., Aimes, R. T., Ward, G. R., Youngleib, G. L. and Quigley, J. P. (1991) Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts. J. Biol. Chem. 266, 5113-5121
32. Rainer, P. P., Hao, S., Vanhoutte, D., Lee, D. I., Koitabashi, N., Molkentin, J. D. et al. (2014) Cardiomyocyte-specific transforming growth factor beta suppression blocks neutrophil infiltration, augments multiple cytoprotective cascades, and reduces early mortality after myocardial infarction. Circ. Res. 114, 1246-1257.
33. Amanso, A. M., Lassegue, B., Joseph, G., Landazuri, N., Long, J. S., Weiss, D. et al. (2014) Polymerase delta-interacting protein 2 promotes postischemic neovascularization of the mouse hindlimb. Arterioscler. Thromb. Vasc. Biol. 34, 1548-1555.
34. Eskandari, M. K., Vijungco, J. D., Flores, A., Borensztajn, J., Shively, V. and Pearce, W. H. (2005) Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice. J. Surg. Res. 123, 289-293.
35. Basu, R., Fan, D., Kandalam, V., Lee, J., Das, S. K., Wang, X. et al. (2012) Loss of Timp3 gene leads to abdominal aortic aneurysm formation in response to angiotensin II. J. Biol. Chem. 287, 44083-44096.
36. Hashizume, R., Yamawaki-Ogata, A., Ueda, Y., Wagner, W. R. and Narita, Y. (2011) Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice. J. Vasc. Surg. 54, 1743-1752.
37. Snider, A. J., Orr Gandy, K. A. and Obeid, L. M. (2010) Sphingosine kinase: role in regulation of bioactive sphingolipid mediators in inflammation. Biochimie 92, 707-715.
38. Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S. et al. (2008) Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 111, 1021-1028.
39. Juvonen, J., Surcel, H. M., Satta, J., Teppo, A. M., Bloigu, A., Syrjala, H. et al. (1997) Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 17, 2843-2847.
40. Rousset, F., Hazane-Puch, F., Pinosa, C., Nguyen, M. V., Grange, L., Soldini, A. et al. (2015) IL-1beta mediates MMP secretion and IL-1beta neosynthesis via upregulation of p22(phox) and NOX4 activity in human articular chondrocytes. Osteoarthritis Cartilage 23, 1972-1980.
41. Fujisaka, S., Usui, I., Ikutani, M., Aminuddin, A., Takikawa, A., Tsuneyama, K. et al. (2013) Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1alpha-dependent and HIF-1alpha-independent manner in obese mice. Diabetologia 56, 1403-1412.
42. Zhang, J., Schmidt, J., Ryschich, E., Mueller-Schilling, M., Schumacher, H. and Allenberg, J. R. (2003) Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J. Vasc. Surg. 38, 360-367.
43. Gavrila, D., Li, W. G., McCormick, M. L., Thomas, M., Daugherty, A., Cassis, L. A. et al. (2005) Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25, 1671-1677.
44. Diebold, I., Petry, A., Hess, J. and Gorlach, A. (2010) The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol. Biol. Cell 21, 2087-2096.
45. Imanishi, M., Chiba, Y., Tomita, N., Matsunaga, S., Nakagawa, T., Ueno, M. et al. (2016) Hypoxia-inducible factor-1alpha in smooth muscle cells protects against aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 36, 2158-2162
46. Yang, L., Shen, L., Li, G., Yuan, H., Jin, X. and Wu, X. (2016) Silencing of hypoxia inducible factor-1alpha gene attenuated angiotensin -induced abdominal aortic aneurysm in apolipoprotein E-deficient mice. Atherosclerosis 252, 40-49.
47. Tsai, S. H., Huang, P. H., Hsu, Y. J., Peng, Y. J., Lee, C. H., Wang, J. C. et al. (2016) Inhibition of hypoxia inducible factor-1alpha attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases. Sci. Rep. 6, 28612.